LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $734M
- YoY, 2025
- +186.3%
- 5-year CAGR
- +12.3%
- 10-year CAGR
- +13.9%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $734M | +186.3% |
| 2024 | $256M | +50.4% |
| 2023 | $170M | −19.6% |
| 2022 | $212M | −37.9% |
| 2021 | $341M | −17.0% |
| 2020 | $411M | −61.6% |
| 2019 | $1.1B | +48.9% |
| 2018 | $718M | +256.2% |
| 2017 | $202M | +43.0% |
| 2016 | $141M | −29.6% |
| 2015 | $200M | +19.7% |
| 2014 | $167M | +947.2% |
| 2013 | $16M | +29.1% |
| 2012 | $12M | −27.3% |
| 2011 | $17M | −24.9% |
| 2010 | $23M | +41.6% |
| 2009 | $16M | — |